Effects of Magnesium Oil Application on the Muscle Contractile Properties

NCT ID: NCT05339308

Last Updated: 2024-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-01

Study Completion Date

2022-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will aim to investigate the effects of magnesium oil administration on skeletal muscle contractile properties.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim: This study will aim to investigate the effects of magnesium oil administration on skeletal muscle contractile properties (SMcp).

Design: Randomized controlled study

Participants: For this purpose, investigators will recruit 40 recreationally active and healthy adults of both sexes (18-35 years of age).

Methods: The experimental leg (EXP) will receive the 10 sprays of magnesium oil (20 mg per spray) that will be topically applied to the skin covering the knee extensor muscles, whereas the control leg (CON) will receive 10 sprays of natural mineral-free oil. The vastus lateralis SMcp will be measured by using a tensiomyography (TMG) device before application (PRE) and after 10 (POST10), 20 (POST20), 30 (POST30), 40 (POST40), and 50 (POST50) minutes of application onset, respectively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Magnesium Skeletal Muscle Contraction Properties

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled study
Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
The participants will not be informed about the actual study purpose, while the main investigator will be blinded to the EXP or CON oil administration

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

Magnesium oil application

Group Type EXPERIMENTAL

Magnesium oil (BetterYou) dermal application

Intervention Type OTHER

10 sprays (200 mg) of magnesium oil (BetterYou) will be applied to skin covering knee extensor muscles. The magnesium oil will be applied only once

Control

Natural mineral-free oil application

Group Type PLACEBO_COMPARATOR

Placebo Control

Intervention Type OTHER

Natural mineral-free oil (10 sprays) will be applied as the control condition. This will be done only once

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnesium oil (BetterYou) dermal application

10 sprays (200 mg) of magnesium oil (BetterYou) will be applied to skin covering knee extensor muscles. The magnesium oil will be applied only once

Intervention Type OTHER

Placebo Control

Natural mineral-free oil (10 sprays) will be applied as the control condition. This will be done only once

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

CONTROL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy, recreationally active adults, no history of neuromuscular and musculoskeletal diseases

Exclusion Criteria

* if some of the criteria are not met
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Masaryk University

OTHER

Sponsor Role collaborator

University of Ljubljana

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Armin Paravlic

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Armin Paravlic, PhD

Role: PRINCIPAL_INVESTIGATOR

Faculty of Sport

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Masaryk University

Brno, , Czechia

Site Status

Faculty of Sport

Ljubljana, Slovenia, Slovenia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia Slovenia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MG-MCP2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NEUROmuscular Training for Enhanced AGE Longevity
NCT06620666 ACTIVE_NOT_RECRUITING NA
Acute Sodium Bicarbonate Supplementation in Athletes
NCT03810404 ACTIVE_NOT_RECRUITING PHASE3